Acknowledgements
MP, Cancer
CANCER
Funding and investigational drugs were provided by BMS (BMS study ID: CA209-8WY). The sponsor was not involved in the trial design, data collection, analysis or manuscript writing. We thank the NGS Core Facility, German Cancer Research Center (DKFZ), for providing excellent sequencing, Illumina Methylation arrays and preliminary data processing services. We thank Michael Menzel, Institute of Pathology, University of Heidelberg, Heidelberg, Germany for his support regarding the availability of sequencing data. MP was supported by the Physician scientist program of the Medical Faculty of the University of Heidelberg.